Jacob Louis Marott1, Truls Sylvan Ingebrigtsen1, Yunus Çolak1,2, Jørgen Vestbo3,4, Peter Lange1,5,6. 1. Copenhagen City Heart Study, Frederiksberg-Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark. 2. Department of Clinical Biochemistry and. 3. Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom. 4. North West Lung Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom; and. 5. Medical Department, Respiratory Section, Herlev-Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. 6. Institute of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
Abstract
Rationale: Chronic obstructive pulmonary disease (COPD) can develop not only through a lung function trajectory dominated by an accelerated decline of FEV1 from normal maximally attained FEV1 in early adulthood (normal maximally attained FEV1 trajectory) but also through a trajectory with FEV1 below normal in early adulthood (low maximally attained FEV1 trajectory). Objectives: To test whether the long-term risk of exacerbations and mortality differs between these two subtypes of COPD. Methods: The cohort included 1,170 young adults enrolled in the Copenhagen City Heart Study during the 1970s and 1980s. In 2001-2003, which served as the baseline for the present analyses, 79 participants had developed COPD through normal maximally attained FEV1 trajectory, 65 had developed COPD through low maximally attained FEV1 trajectory, and 1,026 did not have COPD.Measurements and Main Results: From 2001 until 2018, we observed 139 severe exacerbations of COPD and 215 deaths, of which 55 were due to nonmalignant respiratory disease. In Cox models, there was no difference with regard to risk of severe exacerbations between the two trajectories, but individuals with normal maximally attained FEV1 had an increased risk of nonmalignant respiratory disease mortality (using inverse probability of censoring weighting with adjusted hazard ratio [HR], 6.20; 95% confidence interval [CI], 2.09-18.37; P = 0.001) and all-cause mortality (adjusted HR, 1.93; 95% CI, 1.14-3.26; P = 0.01) compared with individuals with low maximally attained FEV1.Conclusions: COPD developed through normal maximally attained FEV1 trajectory is associated with an increased risk of respiratory and all-cause mortality compared with COPD developed through low maximally attained FEV1 trajectory.
Rationale: Chronic obstructive pulmonary disease (COPD) can develop not only through a lung function trajectory dominated by an accelerated decline of FEV1 from normal maximally attained FEV1 in early adulthood (normal maximally attained FEV1 trajectory) but also through a trajectory with FEV1 below normal in early adulthood (low maximally attained FEV1 trajectory). Objectives: To test whether the long-term risk of exacerbations and mortality differs between these two subtypes of COPD. Methods: The cohort included 1,170 young adults enrolled in the Copenhagen City Heart Study during the 1970s and 1980s. In 2001-2003, which served as the baseline for the present analyses, 79 participants had developed COPD through normal maximally attained FEV1 trajectory, 65 had developed COPD through low maximally attained FEV1 trajectory, and 1,026 did not have COPD.Measurements and Main Results: From 2001 until 2018, we observed 139 severe exacerbations of COPD and 215 deaths, of which 55 were due to nonmalignant respiratory disease. In Cox models, there was no difference with regard to risk of severe exacerbations between the two trajectories, but individuals with normal maximally attained FEV1 had an increased risk of nonmalignant respiratory diseasemortality (using inverse probability of censoring weighting with adjusted hazard ratio [HR], 6.20; 95% confidence interval [CI], 2.09-18.37; P = 0.001) and all-cause mortality (adjusted HR, 1.93; 95% CI, 1.14-3.26; P = 0.01) compared with individuals with low maximally attained FEV1.Conclusions: COPD developed through normal maximally attained FEV1 trajectory is associated with an increased risk of respiratory and all-cause mortality compared with COPD developed through low maximally attained FEV1 trajectory.
Authors: Monica M Vasquez; Muhan Zhou; Chengcheng Hu; Fernando D Martinez; Stefano Guerra Journal: Am J Respir Crit Care Med Date: 2017-05-15 Impact factor: 21.405
Authors: Jørgen Vestbo; Lisa D Edwards; Paul D Scanlon; Julie C Yates; Alvar Agusti; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; William MacNee; Bruce E Miller; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Stephen I Rennard Journal: N Engl J Med Date: 2011-09-26 Impact factor: 91.245
Authors: James C Ross; Peter J Castaldi; Michael H Cho; Craig P Hersh; Farbod N Rahaghi; Gonzalo V Sánchez-Ferrero; Margaret M Parker; Augusto A Litonjua; David Sparrow; Jennifer G Dy; Edwin K Silverman; George R Washko; Raúl San José Estépar Journal: Am J Respir Crit Care Med Date: 2018-10-15 Impact factor: 30.528
Authors: Sigrun Alba Johannesdottir; Erzsébet Horváth-Puhó; Vera Ehrenstein; Morten Schmidt; Lars Pedersen; Henrik Toft Sørensen Journal: Clin Epidemiol Date: 2012-11-12 Impact factor: 4.790
Authors: Andy I Ritchie; Jonathon R Baker; Trisha M Parekh; James P Allinson; Surya P Bhatt; Louise E Donnelly; Gavin C Donaldson Journal: Am J Respir Crit Care Med Date: 2021-07-01 Impact factor: 21.405
Authors: Michael D Weiden; Ankura Singh; David G Goldfarb; Barbara Putman; Rachel Zeig-Owens; Theresa Schwartz; Hillel W Cohen; David J Prezant Journal: Am J Ind Med Date: 2021-07-20 Impact factor: 3.079
Authors: Kiki Waeijen-Smit; Sarah Houben-Wilke; Antonio DiGiandomenico; Ulf Gehrmann; Frits M E Franssen Journal: Intern Emerg Med Date: 2021-02-22 Impact factor: 3.397